# Scientific Consultation: Meeting
The Centers for Disease Control and Prevention (CDC) announces the following meeting:
*Name:* Protocol Review for Neurodevelopmental Evaluation Study.
*Times and Dates:* 10:30 a.m.-5:30 p.m., March 26, 2001; 8:30 a.m.-3:30 p.m., March 27, 2001.
*Place: * Atlanta Marriott Century Center, 2000 Century Boulevard, NE., Atlanta, GA 30345-3377. Telephone: (404) 325-0000.
*Status: * Open to the public, limited only by space available.
*Purpose: * The Centers for Disease Control and Prevention announces a meeting of expert consultants.
*Matters to be Discussed: * The agenda will include the review and discussion on the design of a protocol for a neurodevelopmental examination study looking at thimerosal containing vaccines and the possible association with selected neurodevelopmental outcomes. A period for public comment will be made available each day. Individuals wishing to provide public comment should notify the contact person listed in this announcement.
*Contact Person for More Information:* Gina Mootrey, D.O., M.P.H., Senior Research Officer, Vaccine Safety and Development Activity, Epidemiology and Surveillance Division, National Immunization Program, CDC, 1600 Clifton Road, NE, m/s E61, Atlanta, Georgia 30333. Telephone (404)639-8256.
The Director, Management Analysis and Services office has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Dated: March 8, 2001.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.